Quinovare Participation in BIOHK 2025

QS Medical (Quinovare) will participate in BIOHK 2025, taking place from September 10–13, 2025, in Hong Kong.

During the event, Quinovare will engage with pharmaceutical, biotech, and development partners to discuss needle-free drug delivery platforms and their application across insulin, peptides, proteins, vaccines, and other injectable therapies. Discussions will focus on platform adaptation, combination product development, and potential collaboration models aligned with pharmaceutical development pathways.

BIOHK2025 will feature the Future of Innovative Drugs Forum (Sept 11–12), and we look forward to sharing our vision of how needle-free delivery can accelerate clinical translation and real-world adoption of innovative therapies.

💡 Quinovare’s team will be available for technical and business discussions at Booth T06.

Contact
For meeting requests during BIOHK 2025:
✉ techijet@quinovare.com
🌐 www.techiject.com